
    
      To demonstrate the efficacy of cyclotron-produced Tc-99m pertechnetate (C-PERT; manufactured
      by the Edmonton PET Centre/ERC) in comparison to generator-produced Tc-99m pertechnetate
      (G-PERT; from approved commercial source; using qualitative and quantitative clinical imaging
      biodistribution data.
    
  